Understanding health equity in Alzheimer's treatment for underserved populations
Official title: Health Equity in Alzheimer’s Treatment (HEAT)
Funded at University of Michigan at Ann Arbor · NIH-10975428 · Data updated 2026-11-12
This study is looking at how to make anti-amyloid medications more effective and affordable for Black and low-income people in Flint, Michigan, who are at higher risk for Alzheimer's Disease, by talking to community members about their experiences and challenges with diagnosis and treatment.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project start | August 1, 2024 |
| Project end | July 31, 2025 |
| Funding year | 2024 |
| Award (this year) | $331,439 |
| NIH project number | 1R61AG088891-01 |
| Project ID | NIH-10975428 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include Black individuals and those from low-income backgrounds who are experiencing mild cognitive impairment or Alzheimer's Disease.
✕Less likely to help
Patients who do not belong to Black or low-income populations may not receive direct benefits from this research.
What this research studies
This research investigates how anti-amyloid medications can be effectively and affordably used in Black and low-income populations who are at higher risk for Alzheimer's Disease and related dementias. The project will engage community stakeholders in Flint, Michigan, to gather insights through interviews and surveys about the challenges these populations face regarding diagnosis, treatment, and costs. By focusing on real-world effectiveness and cost-effectiveness, the research aims to identify barriers and preferences that affect treatment outcomes for these communities.
Why it matters
Potential benefit: If successful, this research could lead to improved access and tailored treatment strategies for Alzheimer's patients in underserved populations.
How similar studies have gone: While there has been research on Alzheimer's treatment, this specific focus on health equity in underserved populations is relatively novel and untested.
Where this research is happening
-
University of Michigan at Ann Arbor
Ann Arbor, United States Active
Researchers
- Principal investigator: Callaghan, Brian Christopher — University of Michigan at Ann Arbor
- Study coordinator: Callaghan, Brian Christopher
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.